Notice2022-14757
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 12, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 132 (Tuesday, July 12, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 132 (Tuesday, July 12, 2022)]
[Notices]
[Pages 41319-41320]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-14757]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-0457]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled, ``Aggregate Reports for Tuberculosis Program
Evaluation'' to the Office of Management and Budget (OMB) for review
and approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on March 14,
2022, to obtain comments from the public and affected agencies. CDC did
not receive comments related to the previous notice. This notice serves
to allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden
of the proposed collection of information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information
to be collected;
(d) Minimize the burden of the collection of information on
those who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g.,
permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written
[[Page 41320]]
comments and/or suggestions regarding the items contained in this
notice to the Attention: CDC Desk Officer, Office of Management and
Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Aggregate Reports for Tuberculosis Program Evaluation (OMB Control
No. 0920-0457, Exp. 12/31/2022)--Extension--National Center for HIV,
Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Centers for Disease Control and Prevention, National Center for
HIV, Viral Hepatitis, STD, and TB Prevention, Division of Tuberculosis
Elimination (CDC/NCHHSTP/DTBE) requests an Extension of the Aggregate
Reports for Tuberculosis Program Evaluation information collection,
previously approved under OMB Control No. 0920-0457. This request is
for a three-year period.
The requested Extension allows awardees to address the change in
the national strategies for TB control and prevention emphasizing
treatment of individuals with latent TB infection (LTBI) and at high
risks of progression to TB disease. This data collection will help
programs to assess high-risk populations served and to evaluate the
adaptation and effectiveness of new diagnostic tests and drug regimens
in treating LTBI.
DTBE is the lead agency for tuberculosis elimination in the United
States. To ensure the elimination of tuberculosis in the United States,
CDC monitors indicators for key program activities, such as finding
tuberculosis infections in recent contacts of cases, and in other
persons likely to be infected, and providing therapy for latent
tuberculosis infection. In 2000, CDC implemented two program evaluation
reports for annual submission: (1) Aggregate report of follow-up and
treatment for contacts to tuberculosis cases, and (2) Aggregate report
of targeted testing and treatment for latent tuberculosis infection.
The respondents for these reports are the 67 state and local
tuberculosis control programs receiving federal cooperative agreement
funding through DTBE. These reports emphasize treatment outcomes, high-
priority target populations vulnerable to tuberculosis, and electronic
report entry and submission to CDC through the National Tuberculosis
Indicators Project (NTIP), a secure web-based system for program
evaluation data. No other federal agency collects this type of national
tuberculosis data. The Aggregate report of follow-up for contacts of
tuberculosis and Aggregate report of targeted testing and treatment for
latent tuberculosis infection are the only data source about latent
tuberculosis infection for monitoring national progress toward
tuberculosis elimination with these activities. CDC provides ongoing
assistance in the preparation and utilization of these reports at the
local and state levels of public health jurisdiction. CDC also provides
respondents with technical support for NTIP access.
CDC requests OMB approval for an estimated 268 annual burden hours.
Participation by respondents is voluntary, and there is no cost to
participants other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Health Department Awardee (State, Follow-up and Treatment 67 1 2
Local, City, or other jurisdiction). of Contacts to
Tuberculosis Cases Form
(3a).
Targeted Testing and 67 1 2
Treatment for Latent
Tuberculosis Infection
(3b).
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-14757 Filed 7-11-22; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on July 12, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.